1.19.2019 Issue 155

Visit HealthEconomics.Com Subscribe to Newsletters  |  Contact Us  |  Forward to a Friend
Sponsored by:

This Week's HEOR Jobs Round-up
Job of the Week Latest Jobs from the Jobs Portal

Principal, Pricing Market Access

This role is part of the ICON’s Commercialization and Outcomes Division (ICO). The responsibilities are to recognize, exemplify and adhere to ICON's values which center on our commitment to People, Clients and Performance.

Healthcare Data Scientist

Sr. Director, Health Economics and Outcomes Research

Director, Statistics - Real-World Evidence (Flexible Location)

Managing Consultant – Market Access Consulting (Waltham, MA)

Executive Director, Integrated Solutions - Real-World Evidence (Flexible Location)

Senior Consultant/Consultant

Summer 2019 Internship - Medical Communications

Summer 2019 Internship - Health Economics and Outcomes Research

Report: Biotech Mulls Installments for High-Cost Drugs

J&J Raises Prices after CEO Tells Pharma to Watch Price Hikes

HealthEconomics.Com Founder Talks HEOR, RWE in Publication Planning

ICER Outlines Planned Review of DMD Treatments

Industry Spotlight

Conferences Webinars
Reimbursement and Contracting
    January 23-24, Philadelphia, Pennsylvania

Data Analytics and Decisions
    January 23-24, Philadelphia, Pennsylvania

Special Therapies 2019
    January 24-25, Las Vegas, Nevada

The Payer and Provider Ecosystem Evolution
    January 27-30, San Diego, California

AI and the Augmented Age in Health Care
    January 23

Prove it with PROs?
    January 24

HEOR & RWE: Global Sourcing Strategies and Best Practices
    January 24

Statistical Learning: What Is It? How Does It Relate to Machine Learning and AI? How is It Applied in Healthcare?
    January 30

Conference of the Week Webinar of the Week Job of the Week Link of the Week

Syndicated Reports White Papers
Innovative Drugs: Mapping the Pricing and Reimbursement Landscape

Orphan Drugs: European Payer Perspectives

Do Payers Really Want Pay-for-Performance?

Payer Engagement: Benchmarking Team Structure and Activity

Benchmarking Market Access Strategies for High-Cost Drugs and Biologics

Blockchain: Transformational Change for Pharma?

Time to Market: Accelerating Market Access

Orphan Drugs in the United States

Charting Real World Data and Evidence – Activity and Capabilities (2018)

From Patent to Patient: Analyzing Access to Innovative Cancer Drugs

Transitioning Payment Models: Fee-for-Service to Value-Based Care

How Health Plans and Providers Can Collaborate to Improve Care Transitions and Reduce Hospital Readmissions

Special Thanks to Our Partners:
               Evidera   HealthCore  
      University of FL   Xcenda  OM1    Parexel   Jefferson
      Dymaxium   Precision Xtract    Pharmerit    eMax Health
      Sciformix   Evidence Partners    ICON    Truven